TABLE 2

FROM:

Cancer Research UK procedures in manufacture and toxicology of radiotracers intended for Pre-phase I positron emission tomography studies in cancer patients

E O Aboagye, S K Luthra, F Brady, K Poole, H Anderson, T Jones, A Boobis, S S Burtles and P Price

Table 2. Chemical analysis and set limits on oncology radiopharmaceuticals recently analysed by the Quality Control team at the author's instituion. All samples were analysed by reversed-phase HPLC with UV detection except for 2-[¹⁸F]fluorodeoxyglucose (2-[¹⁸F]FDG) which was analysed by ion-exchange HPLC with pulsed-amperometric detection